Constantin Radu
Papers
1
Total Citations
2
H-Index
1
About
Constantin Radu is a translational scientist whose work bridges high-throughput screening technologies and therapeutic discovery, primarily at Memorial Sloan Kettering Cancer Center (MSKCC). His key research areas include chemical and RNAi screening, drug repurposing, and the development of collaborative platforms to accelerate the fight against disease. Radu’s major contribution is the establishment and operation of MSKCC’s High-Throughput Screening Core Facility (HTSCF), a state-of-the-art platform equipped with advanced robotics and custom-built data management systems. This infrastructure enables the rapid storage, query, and analysis of chemical and RNAi screening data, facilitating the identification of novel therapeutic candidates and the repurposing of existing drugs. His 2014 paper, “Chemical & RNAi Screening at MSKCC,” though with 2 citations, serves as a foundational blueprint for institutional screening efforts, emphasizing open collaboration and data sharing. Radu’s work has directly supported numerous preclinical and clinical studies, making him a key enabler of drug discovery pipelines. His achievements highlight the critical role of core facilities in modern biomedical research, where systematic screening can uncover unexpected vulnerabilities in cancer and other diseases.
Research Focus
Key Achievements
Top Papers
- 1